Interestingly, ADRB1, the β − 1-adrenergic receptor was the second highest impact gene for dilated cardiomyopathy, which is often treated with beta-blockers targeting the adrenergic receptor (S2 Table). Here, ADRB1 is linked to dilated cardiomyopathy.